Home » Νέα


World Hepatitis Day 2019

World Hepatitis Day (WHD) takes places every year on 28 July bringing the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. According to the World Health Organization (WHO), Viral hepatitis B and C affect 325 million people ...

Read More »

FDA Accelerates Review Of Sickle Cell Disease Medicine Crizanlizumab

Novartis announced earlier today the FDA accepted the company’s Biologics License Application (BLA) and has granted Priority Review for its investigational Sickle Cell (SCD) medicine Crizanlizumab. If FDA-approved, crizanlizumab is expected to represent the first monoclonal antibody targeting the P-selectin mediated multi-cellular adhesion in sickle cell disease! Novartis submitted the application ...

Read More »

Drones Land in the Cell and Gene Therapy Space

Cell and gene therapies could be literally flying high soon from now! The Italy-based biotech company Anemocyte, in collaboration with RPS Aerospace,  developed a remotely piloted drone system to securely transport final cell and gene therapy products straight from manufacturing sites to clinical centers. The current prototype can also transport ...

Read More »

Bluebird puts €1.58m price on gene therapy Zynteglo

  Bluebird bio Inc. set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe earlier this month to to treat patients 12 years and older with transfusion-dependent β-thalassaemia (TDT), who have no matching donor for a stem ...

Read More »